(46 days)
Not Found
No
The document describes standard image processing and management functions without mentioning AI or ML.
No
The device is described as providing diagnostic review and analysis of ultrasound images, and its functions include image processing, annotation, analysis, measurement, report generation, communication, storage, and retrieval. These functions are for diagnostic purposes rather than therapeutic intervention.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device "is indicated for diagnostic review and analysis of ultrasound images."
Yes
The device description explicitly states that "EchoPAC will be offered as SW-only to be installed directly on customer PC hardware, or as an accessory to selected 3rd party image management workstations." This indicates a software-only configuration is a primary offering.
Based on the provided information, the GE EchoPAC is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- GE EchoPAC Function: The GE EchoPAC is described as a software device that processes, analyzes, and manages ultrasound images. Ultrasound is an imaging modality that uses sound waves to create images of internal body structures. It does not involve the analysis of specimens taken from the body.
- Intended Use: The intended use clearly states that it is for the "diagnostic review and analysis of ultrasound images acquired via..." various ultrasound modes. This reinforces its role in image interpretation, not specimen analysis.
Therefore, the GE EchoPAC falls under the category of medical imaging software, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The GE EchoPAC is indicated for diagnostic review and analysis of ultrasound images acquired via B (2D), M, Color M modes, Color, Power, Pulsed and CW Doppler modes, Coded Pulse, Harmonic and Real time 3D. Clinical applications include: Fetal; Abdominal (including renal and GYN) ; Urology (including prostate); Pediatric; Small organs (breast, testes, thyroid); Neonatal and Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Transesophageal (TEE); Musculo-skeletal Conventional; Transvaginal (TV); and Intraoperative (abdominal, thoracic and vascular).
The GE EchoPAC Software Only is indicated for diagnostic review and analysis of ultrasound images acquired via B (2D), M, Color M modes, Color, Power, Pulsed and CW Doppler modes, Coded Pulse, Harmonic and Real time 3D. Clinical applications include: Fetal; Abdominal (including renal and GYN) ; Urology (including prostate); Pediatric; Small organs (breast, testes, thyroid); Neonatal and Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Transesophageal (TEE); Musculo-skeletal Conventional; Transrectal (TR); Transvaginal (TV); and Intraoperative (abdominal, thoracic and vascular).
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
GE EchoPAC provides image processing, annotation, analysis, measurement, report generation, communication, storage and retrieval of ultrasound images that are acquired via GE Vivid family of ultrasound scanners, primarily for cardiology ultrasound applications but also for general imaging. The EchoPAC software is an integral component of each Vivid system, providing the post-acquisition image management and reporting functions of the scanner. EchoPAC will be offered as SW-only to be installed directly on customer PC hardware, or as an accessory to selected 3rd party image management workstations. EchoPAC is DICOM compliant, transferring images and data via LAN between scanners, hard copy devices, file servers and other workstations. The modified or added software features for GE EchoPAC are substantially equivalent to the predicate device and functionality cleared on GE EchoPAC K131685
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Fetal; Abdominal (including renal and GYN); Urology (including prostate); Pediatric; Small organs (breast, testes, thyroid); Neonatal and Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Transesophageal (TEE); Musculo-skeletal Conventional; Transrectal (TR); Transvaginal (TV); and Intraoperative (abdominal, thoracic and vascular).
Indicated Patient Age Range
Neonatal and Adult Cephalic; Cardiac (adult and pediatric)
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The subject of this premarket submission. GE EchoPAC, did not require clinical studies to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K131685 GE EchoPAC, K142323 Vivid S60/S70
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines connecting them.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 2, 2015
GE Vingmed Ultrasound AS % Mr. Bryan Behn Regulatory Affairs Manager GE Healthcare 9900 W Innovation Drive, RP-2138 WAUWATOSA WI 53226
Re: K150085
Trade/Device Name: EchoPAC Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: January 14, 2015 Received: January 15, 2015
Dear Mr. Behn:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Robert A Ochs
Robert Ochs. Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
K150085
Device Name EchoPAC
Indications for Use (Describe)
The GE EchoPAC is indicated for diagnostic review and analysis of ultrasound images acquired via B (2D), M, Color M modes, Color, Power, Pulsed and CW Doppler modes, Coded Pulse, Harmonic and Real time 3D. Clinical applications include: Fetal; Abdominal (including renal and GYN) ; Urology (including prostate); Pediatric; Small organs (breast, testes, thyroid); Neonatal and Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Transesophageal (TEE); Musculo-skeletal Conventional; Transvaginal (TV); and Intraoperative (abdominal, thoracic and vascular).
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' intertwined within a circular frame. The frame has a swirling design, giving it a dynamic and recognizable appearance. The logo is presented in a light blue color.
Section 5: 510(k) Summary
GE EchoPAC
4
Image /page/4/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' intertwined within a circular frame. The frame has a swirling design, giving it a dynamic and recognizable appearance. The logo is presented in a light blue color.
510(k) Summary
| In accordance with 21 CFR 807.92 the following summary of information is provided: | |
|---|---|
| Date: | January 14, 2015 |
| Submitter: | GE Healthcare |
| 9900 Innovation Dr | |
| Wauwatosa, WI 53226 | |
| Primary Contact Person: | Bryan Behn |
| Regulatory Affairs Manager | |
| GE Healthcare | |
| T:(414)721-4214 | |
| F:(414)918-8275 | |
| Secondary Contact Person: | Charlotte Kaas Munthe Jørgensen |
| Regulatory Affairs Specialist | |
| GE Vingmed Ultrasound AS | |
| T: +47 97 06 26 46 | |
| F: +47 33 02 12 80 | |
| Device: Trade Name: | GE EchoPAC Workstation Software for ultrasound image review, |
| analysis and reporting | |
| Common/Usual Name: | EchoPAC |
| Classification Names: | Class II |
| Product Code: | 21 CFR 892.2050 |
| Predicate Device(s): | K131685 GE EchoPAC |
| K142323 Vivid S60/S70 | |
| Device Description: | GE EchoPAC provides image processing, annotation, analysis, |
| measurement, report generation, communication, storage and | |
| retrieval of ultrasound images that are acquired via GE Vivid | |
| family of ultrasound scanners, primarily for cardiology | |
| ultrasound applications but also for general imaging. The | |
| EchoPAC software is an integral component of each Vivid | |
| system, providing the post-acquisition image management and | |
| reporting functions of the scanner. EchoPAC will be offered as | |
| SW-only to be installed directly on customer PC hardware, or as | |
| an accessory to selected 3rd party image management | |
| workstations. EchoPAC is DICOM compliant, transferring | |
| images and data via LAN between scanners, hard copy devices, | |
| file servers and other workstations. The modified or added | |
| software features for GE EchoPAC are substantially equivalent to | |
| the predicate device and functionality cleared on GE EchoPAC | |
| K131685 | |
| Intended Use: | The GE EchoPAC Software Only is indicated for diagnostic |
| review and analysis of ultrasound images acquired via B (2D), M, | |
| Color M modes, Color, Power, Pulsed and CW Doppler modes. |
5
Image /page/5/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' written in a stylized script, enclosed within a blue circular frame. The frame has decorative swirls or flourishes extending outward from the circle, giving it a distinctive and recognizable appearance.
Coded Pulse, Harmonic and Real time 3D. Clinical applications include: Fetal; Abdominal (including renal and GYN) ; Urology (including prostate); Pediatric; Small organs (breast, testes, thyroid); Neonatal and Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Transesophageal (TEE); Musculo-skeletal Conventional; Transrectal (TR); Transvaginal (TV); and Intraoperative (abdominal, thoracic and vascular).
Technology: The GE EchoPAC employs the same fundamental scientific technology as its predicate devices.
Determination of Substantial Equivalence: The GE EchoPAC systems are substantially equivalent to the predicate devices with regard to intended use, imaging capabilities, technological characteristics and safety and effectiveness.
| | Proposed Device
GE EchoPAC | Predicate Device
GE EchoPAC
(K131685 ) |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|-------------------------------------------------------------------------|
| Indications and Clinical Applications: | | |
| • Fetal; | ✓ | ✓ |
| • Abdominal (Including
Renal & Gyn) | ✓ | ✓ |
| • Urology (including
prostate); | ✓ | ✓ |
| • Pediatric | ✓ | ✓ |
| • Small Organ (breast, testes,
thyroid); | ✓ | ✓ |
| • Neonatal and Adult
Cephalic; | ✓ | ✓ |
| • Cardiac (adult and
pediatrics); | ✓ | ✓ |
| • Peripheral Vascular; | ✓ | ✓ |
| • Transesophageal (TEE); | ✓ | ✓ |
| • Musculo-skeletal
Conventional | ✓ | ✓ |
| • Transrectal (TR); | ✓ | ✓ |
| • Transvaginal (TV); | ✓ | ✓ |
| • Intraoperative (abdominal,
thoracic, & vascular). | ✓ | ✓ |
| Image modes: | | |
| B (2D), M, Color M modes, Color,
Power, Pulsed and CW Doppler
modes, Coded Pulse, Harmonic and
Real time 3D | ✓ | ✓ |
| Processing &Display features: | | |
| Image mapping (color &
gray), Time/ spatial filtering
and enhancement, TGC, TVI,
SI/SRI, TSI, Harmonic
Imaging, Pulsatile-Flow, B-
Flow, Extended FOV, Tissue
Tracking, Realtime 3D and
Multi-plane processing, 2D
Stress and Multiplane Stress,
4D Stress, TSI w/ surface
rendering, Blood Flow
Imaging (BFI), Spatial
Compounding / Speckle
Reduction imaging, LCD
display, Realtime 3D Color
Flow, Automated Functional
Imaging (AFI), Triplane AFI,
Auto EF (2D), Depth Color
Rendering/map, Depth
Illumination map, Stereo
Vision (Anaglyph Stereo
Vision and Polarized Stereo
Vision), 2 Click Crop,
FlexiSlice, LaserLines, Auto
ROI, | ✓ | ✓ |
| HD live, | | ✓
(Improvement to
Depth
Illumination
Map) |
| AFI Stress. | | ✓
(same features as
on the predicate
Vivid S60/S70
K142323) |
| Measurement & Analysis
Length, Area, Time, Circumference,
Volume, Heart rate, Slope, Velocity,
Angle, Thickness Measurement Tool
(IMT), OB Tables, Vascular and
Cardiac calcs. including Strain (2D
and 4D) and Strain rate, 4D LV
Function by TomTec, 4D RV Function
by TomTec, 4D LV Mass, Mitral
Valve (MV) Quantification tool by
TomTec, Z-score, LA Volume by
Biplane Simpson, 4D Auto LVQ,
Multilayered 2D Strain , ROI width
adjustment, Time Caliper, Export of
4D Strain trace and mesh data, | ✓ | ✓ |
| 4D Auto AVQ. | ✓
(modification of
area
measurements
used in predicate
EchoPAC) | |
6
Image /page/6/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' in a stylized, cursive font, enclosed within a blue circle. There are also some white swirls around the letters. The logo is simple and recognizable, representing the multinational conglomerate corporation.
GE Healthcare 510(k) Premarket Notification Submission
7
Image /page/7/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' in a stylized, cursive font, enclosed within a blue circle. Three white swirls surround the circle, adding a dynamic element to the design. The logo is simple, recognizable, and represents the multinational conglomerate corporation.
GE Healthcare 510(k) Premarket Notification Submission
Summary of Non-Clinical Tests:
The GE EchoPAC and its applications comply with voluntary standards. The following quality assurance measures were applied to the development of the system:
-
- IEC 62366, Medical devices Application of usability engineering to medical devices
-
- IEC 62304, Medical device software Software life cycle process, 2006.
-
- NEMA PS 3.1 3.20 (2011), Digital Imaging and Communications in Medicine (DICOM) Set. (Radiology)
-
- ISO 14971 Medical Devices Application of risk management to medical devices
8
The following quality assurance measures are applied to the development of the system:
- Risk Analysis
- Requirements Reviews ●
- Design Reviews
- Testing on unit level (Module verification)
- . Integration testing (System verification)
- Final Acceptance Testing (Validation)
- Performance testing (Verification)
- Safety testing (Verification) .
Summary of Clinical Tests:
The subject of this premarket submission. GE EchoPAC, did not require clinical studies to support substantial equivalence.
- Conclusion: GE Healthcare considers the GE EchoPAC to be as safe, as effective, and performance is substantially equivalent to the predicate devices.